Observation unit management of acute decompensated heart failure.
Acute decompensated heart failure (ADHF) is a common illness presenting to the emergency department (ED) that is amenable to observation unit (OU) treatment. As the number of baby boomers continues to grow and the incidence of heart failure increases, the financial implications of ADHF treatment will become more prominent. Obtaining institutional support and developing a good working relationship with cardiology colleagues is vital to creating workable ADHF protocols for whichever type of OU an institution decides to use.
Schrock
Jon W
JW
Department of Emergency Medicine, MetroHealth Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH 44109-1998, USA. jschrock@metrohealth.org
Emerman
Charles L
CL
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage; D014487:Centers for Medicare and Medicaid Services, U.S.; D002985:Clinical Protocols; D003362:Cost-Benefit Analysis; D004636:Emergency Service, Hospital / Q000191:economics / Q000458:organization & administration*; D006333:Heart Failure / Q000188:drug therapy / Q000191:economics / Q000628:therapy*; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D006830:Hydralazine / Q000008:administration & dosage; D038801:International Classification of Diseases; D007902:Length of Stay; D045283:Natriuretic Agents / Q000008:administration & dosage; D020097:Natriuretic Peptide, Brain / Q000008:administration & dosage; D018579:Patient Selection; D011175:Positive-Pressure Respiration; D014481:United States
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D045283:Natriuretic Agents; D020097:Natriuretic Peptide, Brain; D006830:Hydralazine